| Longitudinal analyses reveal immunological misfiring in severe COVID-19 C Lucas, P Wong, J Klein, TBR Castro, J Silva, M Sundaram, ... Nature 584 (7821), 463-469, 2020 | 1569 | 2020 |
| Sex differences in immune responses that underlie COVID-19 disease outcomes T Takahashi, MK Ellingson, P Wong, B Israelow, C Lucas, J Klein, J Silva, ... Nature 588 (7837), 315-320, 2020 | 1100 | 2020 |
| Neuroinvasion of SARS-CoV-2 in human and mouse brain E Song, C Zhang, B Israelow, A Lu-Culligan, AV Prado, S Skriabine, P Lu, ... Journal of Experimental Medicine 218 (3), 2021 | 710 | 2021 |
| Diverse functional autoantibodies in patients with COVID-19 EY Wang, T Mao, J Klein, Y Dai, JD Huck, JR Jaycox, F Liu, T Zhou, ... Nature 595 (7866), 283-288, 2021 | 567 | 2021 |
| High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries G Mullokandov, A Baccarini, A Ruzo, AD Jayaprakash, N Tung, ... Nature methods 9 (8), 840-846, 2012 | 392 | 2012 |
| Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling B Israelow, E Song, T Mao, P Lu, A Meir, F Liu, MM Alfajaro, J Wei, ... Journal of Experimental Medicine 217 (12), 2020 | 318 | 2020 |
| SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity CBF Vogels, AE Watkins, CA Harden, DE Brackney, J Shafer, J Wang, ... Med 2 (3), 263-280. e6, 2021 | 220 | 2021 |
| Delayed production of neutralizing antibodies correlates with fatal COVID-19 C Lucas, J Klein, ME Sundaram, F Liu, P Wong, J Silva, T Mao, JE Oh, ... Nature medicine 27 (7), 1178-1186, 2021 | 172 | 2021 |
| HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle CM Narbus, B Israelow, M Sourisseau, ML Michta, SE Hopcraft, ... Journal of virology 85 (22), 12087-12092, 2011 | 152 | 2011 |
| Inflammasome activation in infected macrophages drives COVID-19 pathology E Sefik, R Qu, C Junqueira, E Kaffe, H Mirza, J Zhao, JR Brewer, A Han, ... Nature 606 (7914), 585-593, 2022 | 134 | 2022 |
| Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2 B Israelow, T Mao, J Klein, E Song, B Menasche, SB Omer, A Iwasaki Science immunology 6 (64), eabl4509, 2021 | 102 | 2021 |
| Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms E Song, CM Bartley, RD Chow, TT Ngo, R Jiang, CR Zamecnik, ... Cell Reports Medicine 2 (5), 100288, 2021 | 98 | 2021 |
| Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies M Sourisseau, ML Michta, C Zony, B Israelow, SE Hopcraft, CM Narbus, ... PLoS pathogens 9 (3), e1003244, 2013 | 98 | 2013 |
| Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation A Fernández-Castañeda, P Lu, AC Geraghty, E Song, MH Lee, J Wood, ... Cell 185 (14), 2452-2468. e16, 2022 | 82 | 2022 |
| Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality J Silva, C Lucas, M Sundaram, B Israelow, P Wong, J Klein, M Tokuyama, ... MedRxiv, 2021 | 75 | 2021 |
| HepG2 cells mount an effective antiviral interferon‐lambda based innate immune response to hepatitis C virus infection B Israelow, CM Narbus, M Sourisseau, MJ Evans Hepatology 60 (4), 1170-1179, 2014 | 69 | 2014 |
| Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors B Israelow, G Mullokandov, J Agudo, M Sourisseau, A Bashir, ... Nature communications 5 (1), 5408, 2014 | 67 | 2014 |
| Species-specific regions of occludin required by hepatitis C virus for cell entry ML Michta, SE Hopcraft, CM Narbus, Z Kratovac, B Israelow, ... Journal of virology 84 (22), 11696-11708, 2010 | 64 | 2010 |
| Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses T Mao, B Israelow, MA Peña-Hernández, A Suberi, L Zhou, S Luyten, ... Science 378 (6622), eabo2523, 2022 | 62 | 2022 |
| Detection of SARS-CoV-2 RNA by multiplex RT-qPCR E Kudo, B Israelow, CBF Vogels, P Lu, AL Wyllie, M Tokuyama, ... PLoS Biology 18 (10), e3000867, 2020 | 60 | 2020 |
